Kamal Hamed

Kamal Hamed

No open positions remaining
65 year
Health Technology
Consumer Services

Profile

Kamal Hamed currently works at Spero Therapeutics, Inc., as Chief Medical Officer from 2022.
Dr. Hamed also formerly worked at Novartis, Inc., as Head-Therapeutic Area from 2005 to 2017, Basilea Pharmaceutica AG, as Head-Clinical Development & Medical Affairs from 2017 to 2022, and Lysovant Sciences, Inc., as Chief Medical Officer in 2022.
Dr. Hamed received his graduate degree from The Johns Hopkins University, Masters Business Admin degree from the University of South Florida, and doctorate degree from American University of Beirut.

Former positions of Kamal Hamed

CompaniesPositionEnd
SPERO THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 01/08/2024
Lysovant Sciences, Inc.
Chief Tech/Sci/R&D Officer 01/08/2022
BASILEA PHARMACEUTICA AG Chief Tech/Sci/R&D Officer 01/02/2022
Corporate Officer/Principal 01/03/2017
See the detail of Kamal Hamed's experience

Training of Kamal Hamed

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

9

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Lysovant Sciences, Inc.